Shandong Sinoglory Health Cash Flow Reinvestment Rate

Latest as of December 2025: 0.69x

Shandong Sinoglory Health cash flow reinvestment rate. Shandong Sinoglory Health (603182) has a Cash Flow Reinvestment Rate of 0.69x as of December 2025, reinvesting CN¥54.79 Million (capex CN¥54.75 Million plus investments CN¥47.63K) from operating cash flow of CN¥79.36 Million. Explore Shandong Sinoglory Health (603182) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.69x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥54.79 Million
Capex + Investments

Operating Cash Flow

CN¥79.36 Million
CNY

Capital Expenditures

CN¥54.75 Million
CNY

Cash Flow Reinvestment Rate of Shandong Sinoglory Health (2020–2025)

Cash flow reinvestment rate of Shandong Sinoglory Health from 2020 to 2025. Historical reinvestment intensity for Shandong Sinoglory Health across 6 annual periods. Explore 603182 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Shandong Sinoglory Health Cash Flow Reinvestment Rate by Year (2020–2025)

Shandong Sinoglory Health cash flow reinvestment rate by year from 2020 to 2025. Year-by-year capital reinvestment analysis for Shandong Sinoglory Health. For the full cash flow conversion analysis, see how efficiently does Shandong Sinoglory Health generate cash.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 0.69x CN¥54.79 Million CN¥79.36 Million CN¥54.75 Million ▼ -45.9%
2024 1.28x CN¥400.44 Million CN¥313.81 Million CN¥399.54 Million ▼ -84.4%
2023 8.19x CN¥305.65 Million CN¥37.34 Million CN¥154.79 Million ▲ +650.5%
2022 1.09x CN¥119.07 Million CN¥109.17 Million CN¥45.29 Million ▼ -26.1%
2021 1.48x CN¥63.94 Million CN¥43.34 Million CN¥33.70 Million ▲ +15.1%
2020 1.28x CN¥140.67 Million CN¥109.73 Million CN¥71.10 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow